The pharmaceutical giant Pfizer said on Monday that it had struck a $160 billion deal, including debt, to merge with Allergan, the maker of Botox, in one of the biggest takeovers in the health care industry.
The agreement would also be the biggest deal in what has been a banner year for mergers, driven in part by consolidation in the health care and pharmaceutical sectors. Merger and acquisition activity worldwide surpassed $4 trillion as of Thursday, for only the second time since Thomson Reuters began...
12:23 Sterling volatile as market speculates on ‘hard Brexit’; investors await May's speech18
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese14
16:22 Trump's first 100 days: Here's what to expect from the market20
14:14 Ford expects $2B net income drop due to pension change14